RedHill Biopharma Shareholders Approve Key Resolutions
Company Announcements

RedHill Biopharma Shareholders Approve Key Resolutions

RedHill Biopharma (RDHL) has released an update.

RedHill Biopharma Ltd. recently held its Annual General Meeting, with shareholders approving all proposed resolutions. Key decisions include the appointment of Kesselman & Kesselman as auditors for 2024, the re-election of two board members alongside a new member, and the approval of restricted share units for non-executive directors, the CEO, and the Chief Commercial Officer.

For further insights into RDHL stock, check out TipRanks’ Stock Analysis page.

Related Articles
TipRanks Auto-Generated NewsdeskRedHill Biopharma to Present Opaganib at U.S. Defense Conference
TipRanks Auto-Generated NewsdeskRedHill Biopharma and Duke Collaborate on Opaganib Development
TheFlyRedHill Biopharma signs research pact with Duke University School of Medicine
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App